Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PureOrigin is a biotechnology company specializing in the development and manufacture of high-purity, clinical-grade extracellular vesicles (EVs) and other cell-derived products. The company leverages a proprietary isolation and characterization platform to produce standardized, potent EV populations from various cell sources, including mesenchymal stem cells (MSCs). PureOrigin's technology is designed to address critical challenges in scalability, purity, and standardization within the regenerative medicine field. Their primary therapeutic focus areas include orthopedics, wound healing, and aesthetic medicine, where they aim to provide off-the-shelf therapeutic solutions. Additionally, the company operates as a contract manufacturer, providing high-quality EV production services for external partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pure Origin.